Celal Bozkurt, Baran Sarıkaya, Serkan Sipahioğlu, Mehmet Akif Altay, Baki Volkan Çetin, Pelin Zeynep Bekin Sarıkaya

Effects of developmental dysplasia of the hip screening program on the treatment strategies: A retrospective study from a tertiary care hospital in the southeast region of Turkey

Objective: The aim of this study was to investigate the effects of the developmental dysplasia of the hip screening program on the treatment procedures in a tertiary health care center. Methods: We retrospectively reviewed all the DDH patients between 2012 and 2019 from the operating theatre records. The patients were separated based on the year of treatment. The rates of each treatment modality were determined respectively from 2012 to 2019, and Pavlik harness usage of the patients were queried. The changes in the rates of several surgical interventions after the start of screening program were identified. Results: Between 2012 and 2019, 831 interventions were applied to 711 DDH patients. Closed Reduction (CR) is the least invasive treatment method, and it increased significantly from 20% to 46%. The rate of Open Reductions (OR) also increased from 3% to 9% at this time period, but it was statistically insignificant. Conversely, Pemberton-Salter Osteotomy (PSO) and Dega-Chiari Osteotomy (DCO) rates decreased significantly (41% to 28% and 9% to 0%, respectively). The rate of PembertonSalter osteotomy with femoral shortening (PSO-FS) rate decreased insignificantly from 27% to 20%. In patients that used Pavlik harness, the most common intervention was CR (83%). In CR group, the screened newborn rate increased more than two times from 2012 to 2019. Conclusion: The results of this study have shown that after the initiation of the screening program for DDH, less invasive treatment modalities such as CR and OR interventions increased, and major bony procedures such as PSO, PSO-FS and DCO interventions decreased. Furthermore, as the screening program advanced, CR rate and the use of Pavlik harness rate in CR interventions increased.

PDF

___

1. Sarıkaya B, Sipahioğlu S, Sarıkaya ZB, Altay MA, Işıkan UE. Pemberton osteotomisi sonrası erken dönem kalça gelişimi: Radyolojik takip. Jt Dis Relat Surg. 2016;27(2):81-86. 10.5606/ehc.2016.18
2. Bialik V, Bialik GM, Blazer S, Sujov P, Weiner F, Berant M. Developmental dysplasia of the hip: A new approach to incidence. Pediatrics. 1999;103(1):93- 99. 10.1542/peds.103.1.93
3. US Preventive Services Task Force. Screening for developmental dysplasia of the hip: recommendation statement. Pediatrics. 2006;117(3):898-902. 10.1542/ peds.2005-1995
4. Paton RW. Screening in developmental dysplasia of the hip (DDH). Surgeon. 2017;15(5):290-296. 10.1016/j.surge.2017.05.002
5. Shorter D, Hong T, Osborn DA. Cochrane review: Screening programmes for developmental dysplasia of the hip in newborn infants. Evid Based Child Health. 2013;8(1):11-54.10.1002/ebch.1891
6. Riccabona M, Schweintzger G, Grill F, Graf R. Screening for developmental hip dysplasia (DDH)—clinically or sonographically? comments to the current discussion and proposals.Pediatr Radiol. 2013;43(5):637-640. 10.1007/s00247-012-2578-9
7. Turkish Public Health Institution-Children and Adolescent Health Department, Infant, Toddler and Adolescent Monitoring Protocols, https://hsgm. saglik.gov.tr/tr/cocukergen-tp-liste/geli%C5%9Fimsel-kal%C3%A7a-displa zisi-gkd-tarama-program%
8. St George J, Kulkarni V, Bellemore M, Little DG, Birke O. Importance of early diagnosis for developmental dysplasia of the hip: A 5-year radiological outcome study comparing the effect of early and late diagnosis. J Paediatr Child Health. 2021;57(1):41-45. 10.1111/jpc.15111
9. Woodacre T, Dhadwal A, Ball T, et al. The costs of late detection of developmental dysplasia of the hip. J Child Orthop. 2014;8(4):325-332. 10.1007/s11832- 014-0599-7
10. Rosendahl K, Markestad T, Lie RT. Ultrasound screening for developmental dysplasia of the hip in the neonate: The effect on treatment rate and prevalence of late cases. Pediatrics. 1994;94(1):47-52.
11. Harper P, Joseph BM, Clarke NMP, et al. International Hip Dysplasia Institute (IHDI). even experts can be fooled: Reliability of clinical examination for diagnosing hip dislocations in newborns. J Pediatr Orthop. 2020;40(8):408- 412. 10.1097/BPO.0000000000001602
12. Laborie LB, Engesæter IØ, Lehmann TG, Eastwood DM, Engesæter LB, Rosendahl K. Screening strategies for hip dysplasia: Long-term outcome of a randomized controlled trial. Pediatrics. 2013;132(3):492-501. 10.1542/ peds.2013-0911
13. Dezateux C, Brown J, Arthur R, Karnon J, Parnaby A. Performance, treatment pathways pathways, and effects of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom. Arch Dis Child. 2003;88(9):753-759. 10.1136/adc.88.9.753
14. Holen KJ, Tegnander A, Bredland T, et al. Universal or selective screening of the neonatal hip using ultrasound? a prospective, randomised trial of 15,529 newborn infants. J Bone Joint Surg Br. 2002;84(6):886-890. 10.1302/0301-620X.84B6.0840886
15. Laborie LB, Markestad TJ, Davidsen H, et al. Selective ultrasound screening for developmental hip dysplasia: Effect on management and late detected cases. a prospective survey during 1991–2006. Pediatr Radiol. 2014;44:410-424. 10. 1007/s00247-013-2838-3
16. Ok IY, Kim SJ, Ok JH. Operative treatment of developmental hip dysplasia in children aged over 8 years. J Pediatr Orthop B. 2007;16(4):256-261. 10.1097/ BPB.0b013e32801088f1